Arch Therapeutics to Present AC5 Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)

FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced

GlobeNewswireMay 6 18:50

Arch Therapeutics Provides Year End Operational Update

FRAMINGHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today provided

GlobeNewswireNov 9, 2023 19:50

Arch Therapeutics Files to List Stock, Warrants on Nasdaq

Arch Therapeutics Files to List Stock, Warrants on Nasdaq

Dow JonesNov 9, 2023 19:18

Arch Therapeutics Provides AC5 Commercialization Update

FRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireSep 13, 2023 18:45

Arch Therapeutics Completes Financing as Bridge to Uplisting

FRAMINGHAM, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireSep 8, 2023 07:14

Arch Therapeutics to Present AC5 Advanced Wound System at 2023 Symposium on Advanced Wound Care ("SAWC")

SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS reimbursement codeFRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therap

GlobeNewswireApr 25, 2023 18:56